600479 Stock Overview
Researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
ZhuZhou QianJin Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥10.96 |
52 Week High | CN¥13.89 |
52 Week Low | CN¥8.59 |
Beta | 0.29 |
1 Month Change | -14.91% |
3 Month Change | 15.37% |
1 Year Change | 1.76% |
3 Year Change | -5.27% |
5 Year Change | 26.56% |
Change since IPO | 99.08% |
Recent News & Updates
Shareholder Returns
600479 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.7% | -1.9% | -1.2% |
1Y | 1.8% | -1.8% | 11.8% |
Return vs Industry: 600479 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 600479 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
600479 volatility | |
---|---|
600479 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.8% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600479 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600479's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1966 | 5,335 | Zhiyong Chen | www.qjyy.com |
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China. The company offers traditional Chinese medicine products, including fuke qianjin capsules, chunru gel, buxue yimu pills and granules, fuke duanhongyin capsules, yimu granules, qianjin zhidai pills, fuke tiaojing tablets, jiawei xiaoyao pills, rupikang capsules, lingzhi syrup, xiao'er ganmao granules, fenghan ganmao granules, shujin fengshi medicinal liquor, and shiguogong medicinal liquor; and women's health derivatives, such as qianjin jingya sanitary napkin, qianjin run washing, and care series, etc. It also provides hygienic products, including gynaecological nursing, maternity pad/ maternity package, and baby nursing. In addition, the company provides ginger tea and wine.
ZhuZhou QianJin Pharmaceutical Co.,Ltd Fundamentals Summary
600479 fundamental statistics | |
---|---|
Market cap | CN¥4.65b |
Earnings (TTM) | CN¥291.57m |
Revenue (TTM) | CN¥3.73b |
15.9x
P/E Ratio1.2x
P/S RatioIs 600479 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600479 income statement (TTM) | |
---|---|
Revenue | CN¥3.73b |
Cost of Revenue | CN¥2.02b |
Gross Profit | CN¥1.72b |
Other Expenses | CN¥1.43b |
Earnings | CN¥291.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.69 |
Gross Margin | 45.98% |
Net Profit Margin | 7.81% |
Debt/Equity Ratio | 1.5% |
How did 600479 perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield50%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 10:09 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ZhuZhou QianJin Pharmaceutical Co.,Ltd is covered by 13 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhengwu Wu | AJ Securities Co., Ltd |
Changming He | BOCI Research Ltd. |
Pei Hui Tang | Chasing Securities |